Your browser doesn't support javascript.
loading
KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?
Koistinen, Hannu; Künnapuu, Jaana; Jeltsch, Michael.
Affiliation
  • Koistinen H; Department of Clinical Chemistry, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.
  • Künnapuu J; Drug Research Program, University of Helsinki, 00014 Helsinki, Finland.
  • Jeltsch M; Drug Research Program, University of Helsinki, 00014 Helsinki, Finland.
Int J Mol Sci ; 22(24)2021 Dec 17.
Article in En | MEDLINE | ID: mdl-34948344
ABSTRACT
In this focused review, we address the role of the kallikrein-related peptidase 3 (KLK3), also known as prostate-specific antigen (PSA), in the regulation of angiogenesis. Early studies suggest that KLK3 is able to inhibit angiogenic processes, which is most likely dependent on its proteolytic activity. However, more recent evidence suggests that KLK3 may also have an opposite role, mediated by the ability of KLK3 to activate the (lymph)angiogenic vascular endothelial growth factors VEGF-C and VEGF-D, further discussed in the review.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Kallikreins / Prostate-Specific Antigen / Neovascularization, Pathologic Limits: Humans / Male Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Finland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Kallikreins / Prostate-Specific Antigen / Neovascularization, Pathologic Limits: Humans / Male Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Finland